ArticleAPL bioengineering2018

Identification of on-target mutagenesis during correction of a beta-thalassemia splice mutation in iPS cells with optimised CRISPR/Cas9-double nickase reveals potential safety concerns.

Suad Alateeq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.